Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
C&F Financial | CFFI | Apr 29, 2024 | 39.15 | +1.58 |
C.H. Robinson Worldwide | CHRW | Apr 29, 2024 | 71.70 | +2.11 |
C3.ai | AI | Apr 29, 2024 | 23.10 | +1.18 |
C3is | CISS | Apr 29, 2024 | 1.34 | -0.74 |
C4 Therapeutics | CCCC | Apr 29, 2024 | 6.32 | +2.43 |
Cabaletta Bio | CABA | Apr 29, 2024 | 10.48 | -4.81 |
Cabana Target Drawdown 10 ETF | TDSC | Apr 29, 2024 | 23.68 | +0.64 |
Cabana Target Drawdown 7 ETF | TDSB | Apr 29, 2024 | 21.70 | +0.34 |
Cable One | CABO | Apr 29, 2024 | 398.37 | +2.35 |
Cabot | CBT | Apr 29, 2024 | 93.45 | -0.15 |
CACI International A | CACI | Apr 29, 2024 | 405.01 | +0.03 |
Cactus A | WHD | Apr 29, 2024 | 52.48 | +1.31 |
Cactus Acquisition 1 A | CCTS | Apr 29, 2024 | 11.21 | 0.00 |
Cadeler ADR | CDLR | Apr 29, 2024 | 18.70 | 0.00 |
Cadence Bank | CADE | Apr 29, 2024 | 28.32 | -2.41 |
Cadence Bank A | CADE-A | Apr 29, 2024 | 20.69 | +2.27 |
Cadence Design Systems | CDNS | Apr 29, 2024 | 282.49 | +0.03 |
Cadiz | CDZI | Apr 29, 2024 | 2.26 | +0.44 |
Cadiz Pref ADR | CDZIP | Apr 29, 2024 | 12.49 | +3.93 |
Cadre | CDRE | Apr 29, 2024 | 33.91 | +2.39 |
Cadrenal Therapeutics | CVKD | Apr 29, 2024 | 0.45 | +4.79 |
Cae | CAE | Apr 29, 2024 | 19.36 | +1.68 |
Caesars Entertainment | CZR | Apr 29, 2024 | 37.57 | +2.62 |
Caesarstone | CSTE | Apr 29, 2024 | 5.89 | -4.85 |
Cal-Maine Foods | CALM | Apr 29, 2024 | 57.66 | +1.39 |
Calamos Convertible High Fund | CHY | Apr 29, 2024 | 11.34 | 0.00 |
Calamos Convertible Opportunities And Income Fund | CHI | Apr 29, 2024 | 11.05 | +0.18 |
Calamos Dynamic Convertible & Income Fund | CCD | Apr 29, 2024 | 22.10 | +0.23 |
Calamos Global Dynamic Fund | CHW | Apr 29, 2024 | 6.41 | +1.10 |
Calamos Global Total Return Fund | CGO | Apr 29, 2024 | 10.13 | +0.70 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.